Dolby Laboratories $DLB Shares Purchased by California State Teachers Retirement System

California State Teachers Retirement System boosted its stake in shares of Dolby Laboratories (NYSE:DLBFree Report) by 24.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 72,518 shares of the electronics maker’s stock after acquiring an additional 14,270 shares during the period. California State Teachers Retirement System’s holdings in Dolby Laboratories were worth $4,355,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Quantinno Capital Management LP raised its holdings in shares of Dolby Laboratories by 23.0% in the 1st quarter. Quantinno Capital Management LP now owns 58,316 shares of the electronics maker’s stock valued at $3,503,000 after purchasing an additional 10,887 shares in the last quarter. Entropy Technologies LP acquired a new position in shares of Dolby Laboratories during the first quarter worth $1,674,000. Hilltop Holdings Inc. purchased a new position in Dolby Laboratories in the first quarter valued at $908,000. Modern Wealth Management LLC purchased a new position in Dolby Laboratories in the first quarter valued at $288,000. Finally, Arrowstreet Capital Limited Partnership raised its stake in Dolby Laboratories by 507.5% in the first quarter. Arrowstreet Capital Limited Partnership now owns 124,509 shares of the electronics maker’s stock valued at $7,478,000 after buying an additional 104,014 shares in the last quarter. Hedge funds and other institutional investors own 58.56% of the company’s stock.

Insider Buying and Selling at Dolby Laboratories

In other news, SVP Shriram Revankar sold 3,000 shares of Dolby Laboratories stock in a transaction on Friday, May 15th. The shares were sold at an average price of $54.90, for a total value of $164,700.00. Following the transaction, the senior vice president directly owned 80,603 shares of the company’s stock, valued at $4,425,104.70. The trade was a 3.59% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, SVP John D. Couling sold 7,667 shares of the company’s stock in a transaction on Monday, August 3rd. The shares were sold at an average price of $60.00, for a total transaction of $460,020.00. Following the completion of the sale, the senior vice president owned 118,727 shares of the company’s stock, valued at approximately $7,123,620. This trade represents a 6.07% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last three months, insiders have sold 43,128 shares of company stock valued at $2,405,917. 37.93% of the stock is currently owned by insiders.

Analyst Ratings Changes

A number of analysts have issued reports on DLB shares. Wall Street Zen downgraded Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Barrington Research reiterated an “outperform” rating and issued a $90.00 price objective on shares of Dolby Laboratories in a report on Monday, June 15th. Rosenblatt Securities reissued a “buy” rating and set a $85.00 target price on shares of Dolby Laboratories in a research report on Friday, July 31st. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Wednesday, June 24th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $90.75.

Check Out Our Latest Stock Analysis on DLB

Dolby Laboratories Stock Performance

Shares of DLB stock opened at $61.70 on Friday. The stock’s 50-day moving average is $52.82 and its two-hundred day moving average is $58.49. Dolby Laboratories has a 1 year low of $48.26 and a 1 year high of $75.66. The firm has a market cap of $5.78 billion, a price-to-earnings ratio of 26.26 and a beta of 0.80.

Dolby Laboratories (NYSE:DLBGet Free Report) last posted its earnings results on Thursday, July 30th. The electronics maker reported $0.69 earnings per share for the quarter, beating the consensus estimate of $0.67 by $0.02. The business had revenue of $305.00 million during the quarter, compared to the consensus estimate of $311.96 million. Dolby Laboratories had a return on equity of 11.08% and a net margin of 16.70%.The business’s quarterly revenue was down 3.3% on a year-over-year basis. During the same period in the previous year, the business earned $0.78 EPS. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. As a group, research analysts predict that Dolby Laboratories will post 3.21 EPS for the current year.

Dolby Laboratories announced that its Board of Directors has authorized a stock repurchase program on Thursday, July 30th that allows the company to buyback $350.00 million in shares. This buyback authorization allows the electronics maker to buy up to 7% of its stock through open market purchases. Stock buyback programs are usually a sign that the company’s board believes its shares are undervalued.

Dolby Laboratories Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, August 19th. Stockholders of record on Tuesday, August 11th will be given a dividend of $0.36 per share. The ex-dividend date is Tuesday, August 11th. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.3%. Dolby Laboratories’s dividend payout ratio (DPR) is 61.28%.

Dolby Laboratories Profile

(Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Featured Articles

Want to see what other hedge funds are holding DLB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Dolby Laboratories (NYSE:DLBFree Report).

Institutional Ownership by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.